News, Short Squeeze, Breakout and More Instantly...
Good Works II Acquisition Corp. Company Name:
GWII Stock Symbol:
NASDAQ Market:
Good Works II Acquisition Corp. (Nasdaq: GWII) (“Good Works II”), a publicly traded special purpose acquisition company (“SPAC”), and Direct Biologics, LLC (“Direct Biologics”), a late-stage biotechnology company, today announced the signing of ...
Direct Biologics leverages a proprietary extracellular vesicle platform technology designed to harness the power of bone marrow-derived mesenchymal stem cells to develop cell-free therapeutics Product candidate, ExoFlo ™ , is in a Phase 3 clinical trial for treating...